Drug intelligence / Profile preview

propiolactone

Development stage
Unknown
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Vapor-phase (for Disinfection/sterilization)
01

Overview

Propiolactone (specifically beta-propiolactone) is a small molecule organic compound belonging to the lactones with a four-membered ring structure. It is a colorless liquid with a slightly sweetish and pungent odor. Propiolactone acts as an alkylating agent that reacts readily with nucleophiles via ring-opening reactions. Historically used as an intermediate in the synthesis of acrylic acid and esters and as a sterilant/disinfectant for blood plasma, vaccines, tissue grafts, surgical instruments and enzymes due to its potent sporicidal activity against bacteria (including spores), fungi and viruses. It has also been used to inactivate viruses during vaccine production. However, its use has been largely discontinued or restricted because it is classified as "reasonably anticipated to be a human carcinogen" by IARC; it can cause cancer following exposure[1][2][3][6]. Its mechanism of action involves alkylation of biological macromolecules such as DNA and proteins.

Other names
beta-propiolactoneβ-propiolactone2-oxetanoneoxetan-2-oneoxetan2-oneoxetan 2-onehydracrylic acid β-lactone3-hydroxypropionic acid lactone3-hydroxypropionic acid β-lactone
02

Targets

DNA

Beyond the preview

Go deeper on propiolactone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propiolactone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call